Navigation Links
Consumers are Looking to Boiron Arnicare(R) as a Safer Option as FDA Enforces Stricter Labeling for Many Pain Relievers

NEWTOWN SQUARE, Pa., May 1 /PRNewswire/ -- Many over-the-counter pain relievers will be required to carry stiffer warnings as the United States Food and Drug Administration (FDA) implements its new labeling rules. The final ruling, made Tuesday, calls for stronger labeling on the dangers of liver damage and stomach bleeding for non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, naproxen, and ketoprofen.

Consumers, concerned with NSAIDs and their potential side effects, are turning to Boiron Arnicare as a safer choice for pain relief. Boiron, the leading manufacturer of homeopathic medicines, offers Arnicare as an affordable option for relief of muscle aches and stiffness, due to minor injuries, overexertion, and falls and reduces pain, swelling and discoloration from bruises without side effects or drug interactions. The Arnicare line of pain relievers includes oral pellets and ointment, gel and cream odorless topical formulas, as well as quick-dissolving tablets for arthritis pain.

The main active ingredient in Arnicare is homeopathic Arnica montana, a mountain daisy which is a perennial plant commonly found in the Northwestern parts of the U.S. and Central Europe. Arnica has been used for centuries as a natural pain reliever. Today doctors and pharmacists recommend Arnica in the safe form of a homeopathic medicine in more than 25 countries throughout the world.

Christophe Merville, D.Pharm., pharmacist and director of education and pharmacy development at Boiron, says NSAIDs are a valuable part of a pain relief treatment but they carry some risks. Improved warning labels will better enable consumers to make informed decisions regarding NSAID pain relief medicines and it may also encourage them to try homeopathy as a more natural solution to treating pain without side effects and other safety risks, according to Dr. Merville.

"In light of the FDA ruling on NSAIDs, consumers are wondering if there is a safer, more natural medicine that can ease their pain," Dr. Merville said. "They are finding that Boiron Arnicare is one of the best choices of treatment for both themselves and their families. Arnicare aids in a quick recovery from muscle aches, pain, swelling, as well as bruising, no matter what the activity. Taken at the onset, just when a flare of arthritic pain occurs, or after a trauma or overexertion, or even when the discomfort is caused by a change of weather, Arnicare helps decrease the pain and very often delays or avoids the need for pain killers."

He adds that as with all pain relief medicines, consumers have to review the drug facts carefully on the packaging. He further recommends being cautious not to take pain medicine too frequently or apply it too extensively on areas of the body.

"If you seek relief of general aches or pains throughout your body then I would recommend taking Arnica in pellet form for a systemic effect," he says, adding that for more localized pain applying a thin layer of Boiron Arnicare Gel or Cream on the affected area three times a day is sufficient to provide "adequate relief."

Regulated by the FDA as a drug (1), Arnicare is manufactured according to the Homeopathic Pharmacopoeia of the United States and the Drug Good Manufacturing Practices. For more information or to locate the nearest store that carries the Arnicare line, visit

(1) U.S. Food and Drug Administration. Sec 400.400 Conditions Under Which Homeopathic Drugs May be Marketed (CPG7132.15). Available at:

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Ronald Boyer, M.D. |

Christophe Merville |

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Imported Mexican Food and Beverages Safe for Consumers
2. AVMA Advises Consumers That Pork and Pork Products Are Safe for Consumption
3. MinuteClinic is Educating Consumers About Swine Flu
4. $89 Million Proposed Class Action Settlement Provides Consumers and Insurers With Money Back for Celebrex and Bextra Purchases and Reimbursements
5. Consumers Union Report: Almost 100,000 Surgical Patients Didnt Get the Right Infection Prevention Care During Year Studied
6. An Innovative New Book Helps Consumers Find Out if Their Doctors are Following Official Treatment Guidelines
7. Proposed $350 Million Class Action Settlement Regarding Drug Pricing Provides Consumers and Third-Party Payors With Money Back
8. Hoag named in top 125 hospitals by Consumers' CHECKBOOK as reported by AARP The Magazine
9. Simmons Celebrates Earth Day by Encouraging Consumers To "Sleep Green"
10. Consumers respond to lower calorie beverage options
11. Consumers More Optimistic than Doctors Regarding Future of U.S. Health Care Reform
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the toilets were," said an inventor from Hillside, N.J. "Many people catch diseases ... cover so that individuals will always be protected from germs." , He developed ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Cell Surface Marker Testing Market: ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
Breaking Medicine Technology: